InsidersTradesSigma
Follow the 康弘药业 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 康弘药业 has published 3 reports. Market capitalisation: €19.9bn. The latest transaction was reported on 3 March 2023 (Purchase). Among the most active insiders: 柯潇. All data is openly available.
3
Insider Decl.
n/a
Thresholds
€3m
3 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,640 of 28,802 companies
74.6
score / 100
Value62
Quality88
FCF yld6.2%
Earn yld5.8%
EV/EBITDA13.0x
ROE11%
Gross mgn90%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 March 2023
About 康弘药业
康弘药业 is a company specializing in the health and pharmaceutical sector, offering a range of pharmaceutical products. It is listed on the XSHE market.